Skip to content

Cidofovir

Published: July 26, 2026Updated: August 24, 2026

Cidofovir is an antiviral medication used primarily to treat cytomegalovirus (CMV) retinitis, a serious eye infection that can lead to blindness in immunocompromised patients, particularly those with AIDS. It works as a nucleotide analog that inhibits viral DNA synthesis, preventing the virus from replicating. This medication is typically reserved for patients who cannot tolerate or have not responded to other treatments.

Quick summary

Cidofovir is an antiviral injection used to treat CMV eye infections in immunocompromised patients like those with AIDS, working by inhibiting viral DNA synthesis.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 24, 2026Editorial policy
BOXED WARNING

This medication carries a boxed (black box) warning — the strongest type of FDA warning. Review the full prescribing information before use.

Key facts at a glance

ATC
J05AB12
RxNorm
83171
Generic
Cidofovir
Class
atc-j05
Brands
—
Availability
rx
Pregnancy
C
Lactation
caution
Routes
—
Forms
injection
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity
Chronic overdose: Cumulative dosing above 20 mg/kg associated with increased nephrotoxicity
Immediate actions
discontinue drug, aggressive hydration, monitor renal function, supportive care
Antidote
none(supportive care only, no specific antidote available)
Poison Control: 1-800-222-1222

Special Populations

11 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring and ultrasound assessments

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring and assessment of fetal well-being

Use of this medication in this population requires careful consideration of risks and benefits.

?

lactation

breastfeeding
unknown
FDA Category
N
Dose Adjustment

avoid

Key Recommendations

discontinue breastfeeding or avoid use of cidofovir

Monitor

no data available on excretion in breast milk

⚠

renal_impairment

mild moderate
caution
FDA Category
N
Dose Adjustment

required

Key Recommendations

reduce dose to 1 mg/kg for CrCl 30-55 mL/min; contraindicated for CrCl <30 mL/min without nephrotoxicity

Monitor

monitor serum creatinine and urine protein before each dose; monitor renal function weekly

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
contraindicated
FDA Category
N
Dose Adjustment

contraindicated

Key Recommendations

contraindicated in patients with CrCl <55 mL/min or serum creatinine >1.5 mg/dL

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

hepatic_impairment

mild
caution
FDA Category
N
Dose Adjustment

no specific adjustment

Key Recommendations

use with caution; limited data available

Monitor

monitor liver function tests

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

moderate severe
caution
FDA Category
N
Dose Adjustment

insufficient data

Key Recommendations

use with extreme caution; limited clinical experience

Monitor

close monitoring of liver function and clinical status

Use with caution and monitor for adverse effects.

⚠

pediatric_age

under 2 years
caution
FDA Category
N
Dose Adjustment

insufficient data

Key Recommendations

use only in life-threatening situations; safety and efficacy not established in children <2 years

Monitor

monitor renal function closely; limited pediatric dosing data

Use with caution and monitor for adverse effects.

⚠

pediatric_age

2 to 18 years
caution
FDA Category
N
Dose Adjustment

insufficient data

Key Recommendations

use with caution; pediatric dosing not well established

Monitor

monitor renal function and for adverse effects

Use with caution and monitor for adverse effects.

⚠

geriatric

over 65 years
caution
FDA Category
N
Dose Adjustment

assess renal function

Key Recommendations

use with caution due to age-related decline in renal function; assess renal function before dosing

Monitor

monitor renal function closely before each dose; may have increased sensitivity

Use with caution and monitor for adverse effects.

Statistics and clinical data

prescribingFDA
2023

FDA approval year

Value:1996

Initial FDA approval for CMV retinitis in AIDS patients

drug_classWHO
2023

Drug class

Value:Nucleoside analogue antiviral

Antiviral agent classification

usageFDA
2023

Primary indication

Value:Cytomegalovirus (CMV) retinitis

Main therapeutic use in immunocompromised patients

pharmacologyNIH
2023

Mechanism of action

Value:DNA polymerase inhibitor

Antiviral mechanism of action

Treatment of CMV retinitis in immunocompromised patients, particularly those with AIDS. It may also be used for other CMV infections in patients who cannot tolerate or are refractory to standard treatments like ganciclovir or foscarnet.

Cidofovir is a nucleotide analog that is converted intracellularly to its active form. It inhibits viral DNA polymerase, which is essential for CMV replication, thereby preventing the virus from multiplying and spreading.

Cidofovir is administered by intravenous infusion, typically once weekly initially then every two weeks for maintenance. It carries a significant risk of nephrotoxicity (kidney damage), requiring regular monitoring of kidney function. Probenecid and adequate hydration are given alongside to reduce kidney toxicity. It is contraindicated in patients with pre-existing renal impairment. Other serious side effects may include neutropenia and metabolic abnormalities.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 24, 2026. · Read our editorial policy